Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (23275)
All Articles published online
|
Publishing Process of This Article
|
May 7, 2013 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Marchioni RM, Lichtenstein GR. Tumor necrosis factor-α inhibitor therapy and fetal risk: A systematic literature review. World J Gastroenterol 2013; 19(17): 2591-2602 [PMID: 23674866 DOI: 10.3748/wjg.v19.i17.2591] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i17/2591.htm |
| Number | Citing Articles |
| 1 |
Wendy J. Carman, Neil A. Accortt, Mary S. Anthony, Janet Iles, Cheryl Enger. Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use. Pharmacoepidemiology and Drug Safety 2017; 26(9): 1109 doi: 10.1002/pds.4261
|
| 2 |
J.W. Wieringa, C.J. van der Woude. Effect of biologicals and JAK inhibitors during pregnancy on health-related outcomes in children of women with inflammatory bowel disease. Best Practice & Research Clinical Gastroenterology 2020; : 101665 doi: 10.1016/j.bpg.2019.101665
|
| 3 |
Sarah Madeline Brown, Khadija Aljefri, Rachel Waas, Philip Hampton. Systemic medications used in treatment of common dermatological conditions: safety profile with respect to pregnancy, breast feeding and content in seminal fluid. Journal of Dermatological Treatment 2019; 30(1): 2 doi: 10.1080/09546634.2016.1202402
|
| 4 |
Roxana-Georgiana Juverdeanu, Cayetano Alegre. Fármacos que inhiben el factor de necrosis tumoral α y embarazo. Medicina Clínica 2014; 143(5): 236 doi: 10.1016/j.medcli.2013.10.028
|
| 5 |
Tamara Lund, Simon Francis Thomsen. Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series. Dermatologic Therapy 2017; 30(3): e12454 doi: 10.1111/dth.12454
|
| 6 |
Rena H Cao, Michael C Grimm. Pregnancy and medications in inflammatory bowel disease. Obstetric Medicine 2021; 14(1): 4 doi: 10.1177/1753495X20919214
|
| 7 |
Ariela Hoxha, Antonia Calligaro, Emma Di Poi, Susanna Peccatori, Maria Favaro, Teresa Del Ross, Roberta Ramonda, Chiara Grava, Bernd Raffeiner, Paola Ravagni, Salvatore De Vita, Amelia Ruffatti. Devenir de la grossesse et de l’enfant après traitement par anti-TNF alpha : étude prospective multicentrique. Revue du Rhumatisme 2018; 85(1): 49 doi: 10.1016/j.rhum.2017.07.009
|
| 8 |
Natalia Mena-Vazquez, Sara Manrique-Arija, Antonio Fernandez-Nebro. Safety of biologic therapies during pregnancy in women with rheumatic disease. World Journal of Rheumatology 2015; 5(2): 82-89 doi: 10.5499/wjr.v5.i2.82
|
| 9 |
Anna Felis-Giemza. New era of treatment with biologics in rheumatology – is it time to shift paradigms in treatment with biologics?. Rheumatology 2019; 57(5): 255 doi: 10.5114/reum.2019.89515
|
| 10 |
Juejing Ling, Gideon Koren. Challenges in vaccinating infants born to mothers taking immunoglobulin biologicals during pregnancy. Expert Review of Vaccines 2016; 15(2): 239 doi: 10.1586/14760584.2016.1115351
|
| 11 |
Charlene Porter, Sylvia Armstrong-Fisher, Tim Kopotsha, Bryan Smith, Terry Baker, Lara Kevorkian, Andrew Nesbitt. Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer. Journal of Reproductive Immunology 2016; 116: 7 doi: 10.1016/j.jri.2016.04.284
|
| 12 |
Akarsu Sevgi. Interaction of psoriasis and pregnancy: Maternal and fetal outcomes. Archives of Anatomy and Physiology 2020; 5(1): 001 doi: 10.17352/aap.000013
|
| 13 |
M. V. Shapina, I. L. Khalif, V. A. Nanaeva. CERTOLIZUMAB PEGOL IN CHOHN'S DISEASE (review). Koloproktologia 2016; (3): 102 doi: 10.33878/2073-7556-2016-0-3-102-108
|
| 14 |
I. Belinchón, M. Velasco, M. Ara-Martín, S. Armesto Alonso, O. Baniandrés Rodríguez, L. Ferrándiz Pulido, M. García-Bustinduy, J.A. Martínez-López, N. Martínez Sánchez, A. Pérez Ferriols, E. Pérez Pascual, R. Rivera Díaz, R. Ruiz-Villaverde, R. Taberner Ferrer, A. Vicente Villa, J.M. Carrascosa. Management of Psoriasis During Preconception, Pregnancy, Postpartum, and Breastfeeding: A Consensus Statement. Actas Dermo-Sifiliográficas (English Edition) 2021; 112(3): 225 doi: 10.1016/j.adengl.2020.10.031
|
| 15 |
Jun Zhang, Ying Cui, Yinfang Wu, Huiju Wang, Jinjing Ke. Prediction and identification of B-cell epitopes for tumor necrosis factor-α. Molecular Medicine Reports 2017; 16(3): 3439 doi: 10.3892/mmr.2017.7007
|
| 16 |
David James, Philip J. Steer, Carl P. Weiner, Bernard Gonik, Stephen C, Robson. High-Risk Pregnancy. 2018; doi: 10.1017/9781108349185
|
| 17 |
Ronald F. van Vollenhoven. Biologics for the Treatment of Rheumatoid Arthritis. 2016; : 109 doi: 10.1007/978-3-319-13108-5_9
|
| 18 |
Renata Baronaite Hansen, Arthur Kavanaugh. Certolizumab pegol for the treatment of psoriatic arthritis. Expert Review of Clinical Immunology 2015; 11(3): 307 doi: 10.1586/1744666X.2015.1009897
|
| 19 |
Hye Won Lee, Won Ho Kim, Jae Hee Cheon. The Medical Treatments of Intestinal Behçet's Disease: An Update. Intestinal Research 2013; 11(3): 155 doi: 10.5217/ir.2013.11.3.155
|
| 20 |
Paloma Vela. Pregnancy in Chronic Arthritis: Only a Matter of Planning. EMJ Rheumatology 2015; : 66 doi: 10.33590/emjrheumatol/10312889
|
| 21 |
Corinna Weber-Schöndorfer. Drugs During Pregnancy and Lactation. 2015; : 341 doi: 10.1016/B978-0-12-408078-2.00013-5
|
| 22 |
Karen Priscilla Tezotto Pendeloski, Erika Ono, Maria Regina Torloni, Rosiane Mattar, Silvia Daher. Maternal obesity and inflammatory mediators: A controversial association. American Journal of Reproductive Immunology 2017; 77(5) doi: 10.1111/aji.12674
|
| 23 |
Hideki Fujita, Tadashi Terui, Koremasa Hayama, Masashi Akiyama, Shigaku Ikeda, Tomotaka Mabuchi, Akira Ozawa, Takuro Kanekura, Michiko Kurosawa, Mayumi Komine, Kimiko Nakajima, Shigetoshi Sano, Osamu Nemoto, Masahiko Muto, Yasutomo Imai, Kiyofumi Yamanishi, Yumi Aoyama, Keiji Iwatsuki. Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP. The Journal of Dermatology 2018; 45(11): 1235 doi: 10.1111/1346-8138.14523
|
| 24 |
Batia Weiss, Shomron Ben-Horin, Atar Lev, Efrat Broide, Miri Yavzori, Adi Lahat, Uri Kopylov, Orit Picard, Rami Eliakim, Yulia Ron, Irit Avni-Biron, Anat Yerushalmy-Feler, Amit Assa, Raz Somech, Ariella Bar-Gil Shitrit. Immune function in newborns with in-utero exposure to anti-TNFα therapy. Frontiers in Pediatrics 2022; 10 doi: 10.3389/fped.2022.935034
|
| 25 |
Eric M. George. New Approaches for Managing Preeclampsia: Clues From Clinical and Basic Research. Clinical Therapeutics 2014; 36(12): 1873 doi: 10.1016/j.clinthera.2014.09.023
|
| 26 |
Vedat Goral, Belkis Unsal, Oya Nermin Sivrikoz. A Case of Breast Cancer Following Infliximab Treatment
for Treatment-Refractory Crohn’s Disease. Euroasian Journal of Hepato-Gastroenterology 2014; 4(2): 104 doi: 10.5005/jp-journals-10018-1112
|
| 27 |
Stella X. Chen, Charlotte Greif, Ruby S. Gibson, Martina L. Porter, Alexa B. Kimball. Advances in biologic and small molecule therapies for hidradenitis suppurativa. Expert Opinion on Pharmacotherapy 2022; 23(8): 959 doi: 10.1080/14656566.2022.2070429
|
| 28 |
Corinna Weber‐Schoendorfer, Marc Oppermann, Evelin Wacker, Nathalie Bernard, Delphine Beghin, Benedikte Cuppers‐Maarschalkerweerd, Jonathan L. Richardson, Laura E. Rothuizen, Alessandra Pistelli, Heli Malm, Georgios Eleftheriou, Debra Kennedy, Mine Kadioglu Duman, Reinhard Meister, Christof Schaefer. Pregnancy outcome after TNF‐α inhibitor therapy during the first trimester: a prospective multicentre cohort study. British Journal of Clinical Pharmacology 2015; 80(4): 727 doi: 10.1111/bcp.12642
|
| 29 |
Jamile R. Silva, Lício F.A.A. Ferreira, Percíllia V.S. Oliveira, Ivanéia V. Nunes, Ítalo S. Pereira, Jorge Timenetsky, Lucas M. Marques, Tiana B. Figueiredo, Robson A.A. Silva. Intra-uterine experimental infection by Ureaplasma diversum induces TNF-α mediated womb inflammation in mice. Anais da Academia Brasileira de Ciências 2016; 88(suppl 1): 643 doi: 10.1590/0001-3765201620150244
|
| 30 |
Bengt Källén. Maternal Drug Use and Infant Congenital Malformations. 2019; : 203 doi: 10.1007/978-3-030-17898-7_18
|
| 31 |
Gökçe Işıl Kurmuş, Erol Koç. Different Aspects of Behçet's Disease. 2020; doi: 10.5772/intechopen.88307
|
| 32 |
Geoffrey C. Nguyen, Cynthia H. Seow, Cynthia Maxwell, Vivian Huang, Yvette Leung, Jennifer Jones, Grigorios I. Leontiadis, Frances Tse, Uma Mahadevan, C. Janneke van der Woude, Alain Bitton, Brian Bressler, Sharyle Fowler, John K. Marshall, Carrie Palatnick, Anna Pupco, Joel Ray, Laura Targownik, Janneke van der Woude, William Paterson. The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. Gastroenterology 2016; 150(3): 734 doi: 10.1053/j.gastro.2015.12.003
|
| 33 |
Miguel Ángel Saavedra Salinas, Antonio Barrera Cruz, Antonio Rafael Cabral Castañeda, Luis Javier Jara Quezada, C. Alejandro Arce-Salinas, José Álvarez Nemegyei, Antonio Fraga Mouret, Javier Orozco Alcalá, Mario Salazar Páramo, Claudia Verónica Cruz Reyes, Lilia Andrade Ortega, Olga Lidia Vera Lastra, Claudia Mendoza Pinto, Antonio Sánchez González, Polita del Rocío Cruz Cruz, Sara Morales Hernández, Margarita Portela Hernández, Mario Pérez Cristóbal, Gabriela Medina García, Noé Hernández Romero, María del Carmen Velarde Ochoa, José Eduardo Navarro Zarza, Verónica Portillo Díaz, Angélica Vargas Guerrero, María Victoria Goycochea Robles, José Luis García Figueroa, Eduardo Barreira Mercado, Mary Carmen Amigo Castañeda. Clinical Practice Guidelines for the Management of Pregnancy in Women With Autoimmune Rheumatic Diseases of the Mexican College of Rheumatology. Part II. Reumatología Clínica (English Edition) 2015; 11(5): 305 doi: 10.1016/j.reumae.2015.03.005
|
| 34 |
Robyn Laube, Sudarshan Paramsothy, Rupert W Leong. Use of medications during pregnancy and breastfeeding for Crohn’s disease and ulcerative colitis. Expert Opinion on Drug Safety 2021; 20(3): 275 doi: 10.1080/14740338.2021.1873948
|
| 35 |
Jeff Chang, Rupert WL Leong. Occupational health and safety of anti-tumour necrosis factor alpha monoclonal antibodies with casual exposure. Expert Opinion on Biological Therapy 2014; 14(1): 27 doi: 10.1517/14712598.2014.853738
|
| 36 |
F. Maccari, A.‐C. Fougerousse, E. Esteve, L. Frumholtz, J. Parier, C. Hurabielle, C. Cassius, C. Taieb. Crossed looks on the dermatologist's position and the patient's preoccupations as to psoriasis and pregnancy: preliminary results of the PREGNAN‐PSO study. Journal of the European Academy of Dermatology and Venereology 2019; 33(5): 880 doi: 10.1111/jdv.15423
|
| 37 |
Miguel Ángel Saavedra Salinas, Antonio Barrera Cruz, Antonio Rafael Cabral Castañeda, Luis Javier Jara Quezada, C. Alejandro Arce-Salinas, José Álvarez Nemegyei, Antonio Fraga Mouret, Javier Orozco Alcalá, Mario Salazar Páramo, Claudia Verónica Cruz Reyes, Lilia Andrade Ortega, Olga Lidia Vera Lastra, Claudia Mendoza Pinto, Antonio Sánchez González, Polita del Rocío Cruz Cruz, Sara Morales Hernández, Margarita Portela Hernández, Mario Pérez Cristóbal, Gabriela Medina García, Noé Hernández Romero, María del Carmen Velarde Ochoa, José Eduardo Navarro Zarza, Verónica Portillo Díaz, Angélica Vargas Guerrero, María Victoria Goycochea Robles, José Luis García Figueroa, Eduardo Barreira Mercado, Mary Carmen Amigo Castañeda. Guías de práctica clínica para la atención del embarazo en mujeres con enfermedades reumáticas autoinmunes del Colegio Mexicano de Reumatología. Parte II. Reumatología Clínica 2015; 11(5): 305 doi: 10.1016/j.reuma.2014.12.004
|
| 38 |
Frauke Förger, Astrid Zbinden, Peter M. Villiger. Certolizumab treatment during late pregnancy in patients with rheumatic diseases: Low drug levels in cord blood but possible risk for maternal infections. A case series of 13 patients. Joint Bone Spine 2016; 83(3): 341 doi: 10.1016/j.jbspin.2015.07.004
|
| 39 |
J.K. Yamamoto-Furusho, F. Bosques-Padilla, P. Daffra, J.A. De Paula, J. Etchevers, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.M. Marroquín de la Garza, R. Monreal Robles, J.L. Rocha, F. Steinwurz, R. Vázquez-Frías, G. Veitia, C. Zaltman. Special situations in inflammatory bowel disease: First Latin American consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) (Second part). Revista de Gastroenterología de México (English Edition) 2017; 82(2): 134 doi: 10.1016/j.rgmxen.2016.07.004
|
| 40 |
J.M. Carrascosa, L. Puig, I.B. Romero, L. Salgado-Boquete, E. del Alcázar, J.J.A. Lencina, D. Moreno, P. de la Cueva. Actualización práctica de las recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (GPS) para el tratamiento de la psoriasis con terapia biológica. Parte 2 «Manejo de poblaciones especiales, pacientes con comorbilidad y gestión del riesgo». Actas Dermo-Sifiliográficas 2022; 113(6): 583 doi: 10.1016/j.ad.2022.01.024
|
| 41 |
J.M. Carrascosa, L. Puig, I.B. Romero, L. Salgado-Boquete, E. del Alcázar, J.J.A. Lencina, D. Moreno, P. de la Cueva. [Translated article] Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2—Management of Special Populations, Patients With Comorbid Conditions, and Risk. Actas Dermo-Sifiliográficas 2022; 113(6): T583 doi: 10.1016/j.ad.2022.01.040
|
| 42 |
J.K. Yamamoto-Furusho, F. Bosques-Padilla, P. Daffra, J.A. De Paula, J. Etchevers, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.M. Marroquín de la Garza, R. Monreal Robles, J.L. Rocha, F. Steinwurz, R. Vázquez-Frías, G. Veitia, C. Zaltman. Situaciones especiales en la enfermedad inflamatoria intestinal: primer consenso latinoamericano de la Pan American Crohn's and Colitis Organisation (PANCCO) (Segunda parte). Revista de Gastroenterología de México 2017; 82(2): 134 doi: 10.1016/j.rgmx.2016.07.005
|
| 43 |
Megan E.B. Clowse, Douglas C. Wolf, Frauke Förger, John J. Cush, Amanda Golembesky, Laura Shaughnessy, Dirk De Cuyper, Uma Mahadevan. Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol. The Journal of Rheumatology 2015; 42(12): 2270 doi: 10.3899/jrheum.140189
|
| 44 |
P A Shesternya, M M Petrova, A O Vasilyeva. New horizons in the use of biological agents during pregnancy in patients with rheumatic disease. Terapevticheskii arkhiv 2017; 89(5): 105 doi: 10.17116/terarkh2017895105-112
|
| 45 |
Arsène Mekinian, Jonathan Cohen, Jaume Alijotas‐Reig, Lionel Carbillon, Pascale Nicaise‐Roland, Gilles Kayem, Emile Daraï, Olivier Fain, Marie Bornes. Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?. American Journal of Reproductive Immunology 2016; 76(1): 8 doi: 10.1111/aji.12493
|
| 46 |
Ariela Hoxha, Antonia Calligaro, Emma Di Poi, Susanna Peccatori, Maria Favaro, Teresa Del Ross, Roberta Ramonda, Chiara Grava, Bernd Raffeiner, Paola Ravagni, Salvatore De Vita, Amelia Ruffatti. Pregnancy and foetal outcomes following anti-tumor necrosis factor alpha therapy: A prospective multicentre study. Joint Bone Spine 2017; 84(2): 169 doi: 10.1016/j.jbspin.2016.03.014
|
| 47 |
Bram P. Wispelwey, Eyal Sheiner. Inflammatory bowel disease and preterm delivery. Archives of Gynecology and Obstetrics 2013; 288(4): 725 doi: 10.1007/s00404-013-2989-3
|
| 48 |
Uma Mahadevan, Saule Naureckas, Ilia Tikhonov, Yiting Wang, Connie B. Lin, Anja Geldhof, C. Janneke van der Woude. Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer's global safety database. Alimentary Pharmacology & Therapeutics 2022; 56(3): 477 doi: 10.1111/apt.16960
|
| 49 |
Kristel K Leung, Parul Tandon, Vivek Govardhanam, Cynthia Maxwell, Vivian Huang. The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflammatory Bowel Diseases 2021; 27(4): 550 doi: 10.1093/ibd/izaa122
|
| 50 |
Michiel F. Schreuder, Huib de Jong, Ellen C. van der Kuur, Elisabeth A.M. Cornelissen. Transient generalized proximal tubular dysfunction in an infant with a urinary tract infection: the effect of maternal infliximab therapy?. Case Reports in Perinatal Medicine 2021; 10(1) doi: 10.1515/crpm-2020-0050
|
| 51 |
Nicole W. Tsao, Larry D. Lynd, Mohsen Sadatsafavi, Gillian Hanley, Mary A. De Vera. Patterns of Biologics Utilization and Discontinuation Before and During Pregnancy in Women With Autoimmune Diseases: A Population‐Based Cohort Study. Arthritis Care & Research 2018; 70(7): 979 doi: 10.1002/acr.23434
|
| 52 |
Han Wang, Yue Hu, Fang Chen, Mengdie Shen. Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis. BMC Pregnancy and Childbirth 2022; 22(1) doi: 10.1186/s12884-022-05191-z
|
| 53 |
Konstantinos Papamichael, Gerassimos J. Mantzaris, Laurent Peyrin-Biroulet. A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn’s disease. Expert Opinion on Drug Safety 2016; 15(4): 493 doi: 10.1517/14740338.2016.1145653
|
| 54 |
Frauke Förger, Astrid Zbinden, Peter M. Villiger. Traitement par certolizumab en fin de grossesse chez les patientes atteintes de maladies rhumatismales : faibles concentrations du médicament dans le sang du cordon ombilical mais risques possibles d’infections maternelles. Une série de 13 cas. Revue du Rhumatisme 2016; 83(3): 226 doi: 10.1016/j.rhum.2016.02.011
|
| 55 |
Anita Afzali. Inflammatory bowel disease during pregnancy. Current Opinion in Gastroenterology 2019; 35(4): 281 doi: 10.1097/MOG.0000000000000541
|
| 56 |
Uma Mahadevan, Millie D. Long, Sunanda V. Kane, Abhik Roy, Marla C. Dubinsky, Bruce E. Sands, Russell D. Cohen, Christina D. Chambers, William J. Sandborn. Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease. Gastroenterology 2021; 160(4): 1131 doi: 10.1053/j.gastro.2020.11.038
|
| 57 |
Oier Ateka-Barrutia, Catherine Nelson-Piercy. Connective tissue disease in pregnancy. Clinical Medicine 2013; 13(6): 580 doi: 10.7861/clinmedicine.13-6-580
|
| 58 |
A. Mekinian, J. Cohen, G. Kayem, L. Carbillon, P. Nicaise-Roland, B. Gaugler, E. Darai, M. Bornes, O. Fain. Fausses couches précoces récurrentes inexpliquées : quelle est la place de l’immunomodulation ?. La Revue de Médecine Interne 2017; 38(4): 264 doi: 10.1016/j.revmed.2016.08.001
|
| 59 |
Lindsay Lally, Robert F. Spiera. Contraception and Pregnancy in Patients with Rheumatic Disease. 2014; : 171 doi: 10.1007/978-1-4939-0673-4_9
|
| 60 |
Birgit M. Köhler, Janine Günther, Dorothee Kaudewitz, Hanns-Martin Lorenz. Current Therapeutic Options in the Treatment of Rheumatoid Arthritis. Journal of Clinical Medicine 2019; 8(7): 938 doi: 10.3390/jcm8070938
|
| 61 |
Kara M. De Felice, Sunanda Kane. Safety of anti-TNF agents in pregnancy. Journal of Allergy and Clinical Immunology 2021; 148(3): 661 doi: 10.1016/j.jaci.2021.07.005
|
| 62 |
Fang-fang Dai, Min Hu, Yu-wei Zhang, Rong-hui Zhu, Li-ping Chen, Zhi-dian Li, Yan-jie Huang, Wei Hu, Yan-xiang Cheng. TNF-α/anti-TNF-αdrugs and its effect on pregnancy outcomes. Expert Reviews in Molecular Medicine 2022; 24 doi: 10.1017/erm.2022.18
|
| 63 |
Gabriella Bröms, Fredrik Granath, Anders Ekbom, Karin Hellgren, Lars Pedersen, Henrik T. Sørensen, Olof Stephansson, Helle Kieler. Low Risk of Birth Defects for Infants Whose Mothers Are Treated With Anti–Tumor Necrosis Factor Agents During Pregnancy. Clinical Gastroenterology and Hepatology 2016; 14(2): 234 doi: 10.1016/j.cgh.2015.08.039
|
| 64 |
Wenfei Zheng, Manshu Lei, Yao Yao, Jingqiong Zhan, Yiming Zhang, Quan Zhou. Mechanisms underlying the therapeutic effects of Semen cuscutae in treating recurrent spontaneous abortion based on network pharmacology and molecular docking. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1282100
|
| 65 |
Benjamin Hassid, Uma Mahadevan. The use of biologic therapy in pregnancy. Current Opinion in Rheumatology 2014; 26(3): 347 doi: 10.1097/BOR.0000000000000048
|
| 66 |
K. L. Hyrich, S. M. M. Verstappen. Biologic therapies and pregnancy: the story so far. Rheumatology 2014; 53(8): 1377 doi: 10.1093/rheumatology/ket409
|
| 67 |
Gene‐Siew Ngian, Andrew M. Briggs, Ilana N. Ackerman, Sharon Van Doornum. Safety of anti‐rheumatic drugs for rheumatoid arthritis in pregnancy and lactation. International Journal of Rheumatic Diseases 2016; 19(9): 834 doi: 10.1111/1756-185X.12860
|
| 68 |
Vivian Wai-Mei Huang, Hsiu-Ju Chang, Karen Ivy Kroeker, Karen Jean Goodman, Kathleen M. Hegadoren, Levinus Albert Dieleman, Richard Neil Fedorak. Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding Varies Widely: A Need for Further Education. Canadian Journal of Gastroenterology and Hepatology 2016; 2016: 1 doi: 10.1155/2016/6193275
|
| 69 |
Lorena Tonarelli. Navigating the Road to Psoriasis Control in Women: Strategies to Optimise the Reproductive Journey. EMJ Dermatology 2019; : 45 doi: 10.33590/emjdermatol/10310912
|
| 70 |
Megan L. Krause, Shreyasee Amin, Ashima Makol. Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to know. Therapeutic Advances in Musculoskeletal Disease 2014; 6(5): 169 doi: 10.1177/1759720X14551568
|
| 71 |
K. Vigl, C. Posch, L. Richter, B. Monshi, K. Rappersberger. Pyoderma gangrenosum during pregnancy – treatment options revisited. Journal of the European Academy of Dermatology and Venereology 2016; 30(11): 1981 doi: 10.1111/jdv.13792
|
| 72 |
Martin Bortlik, Dana Duricova, Nadezda Machkova, Jana Kozeluhova, Pavel Kohout, Ludek Hrdlicka, Marianna Durilova, Katarina Mitrova, Ondrej Hradsky, Jiri Bronsky, Karin Malickova, Milan Lukas. Impact of Anti–Tumor Necrosis Factor Alpha Antibodies Administered to Pregnant Women With Inflammatory Bowel Disease on Long-term Outcome of Exposed Children. Inflammatory Bowel Diseases 2014; 20(3): 495 doi: 10.1097/01.MIB.0000440984.86659.4f
|
| 73 |
Yan Sun, Wensheng Pan, Jun Zhang, Ying Cui, Huiju Wang, Guoqing Ru, Legao Chen. Complex TNF-α B cell epitope MAP vaccine alleviates murine ulcerative colitis. International Journal of Molecular Medicine 2019; doi: 10.3892/ijmm.2019.4271
|
| 74 |
Wendy Marder, Emily A. Littlejohn, Emily C. Somers. Pregnancy and autoimmune connective tissue diseases. Best Practice & Research Clinical Rheumatology 2016; 30(1): 63 doi: 10.1016/j.berh.2016.05.002
|
| 75 |
|
| 76 |
Halil Aşçı, Mehtap Savran, Sıla Gülbağ Pınar, Nasıf Fatih Karakuyu, Orhan İmeci, Mehmer Abdulkadir Sevük, Mekin Sezik, Özlem Özmen. Evaluation of the mixture "MagSelDex" for neuroprotection against offspring brain injury in endotoxin-induced chorioamnionitis: A Preliminary Study. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi 2024; 15(1): 49 doi: 10.22312/sdusbed.1347232
|
| 77 |
Jantien W. Wieringa, Gertjan J. Driessen, C. Janneke Van Der Woude. Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system. Expert Review of Gastroenterology & Hepatology 2018; 12(8): 811 doi: 10.1080/17474124.2018.1496820
|
| 78 |
Miguel A. Saavedra, Roxana Romo-Rodríguez, Sergio R. Gutiérrez-Ureña, Dafhne Miranda-Hernández, Lilia I. Hernández-Cruz, Luis J. Jara. Targeted drugs in spondyloarthritis during pregnancy and lactation. Pharmacological Research 2018; 136: 21 doi: 10.1016/j.phrs.2018.08.009
|
| 79 |
Reyhaneh Moghaddami, Mahdi Mahdipour, Ehsan Ahmadpour. Inflammatory pathways of Toxoplasma gondii infection in pregnancy. Travel Medicine and Infectious Disease 2024; 62: 102760 doi: 10.1016/j.tmaid.2024.102760
|
| 80 |
Keita Fujikawa, Yushiro Endo, Akinari Mizokami, Kosuke Takahashi, Maiko Tabuchi, Kazuo Ohba, Hideki Nakamura, Atsushi Kawakami. Successful Treatment with Adalimumab for Intestinal Behcet's Disease during Pregnancy. Internal Medicine 2016; 55(10): 1375 doi: 10.2169/internalmedicine.55.6590
|
| 81 |
Sara Horst, Sunanda Kane. The Use of Biologic Agents in Pregnancy and Breastfeeding. Gastroenterology Clinics of North America 2014; 43(3): 495 doi: 10.1016/j.gtc.2014.05.005
|
| 82 |
C Janneke van der Woude, Herold J Metselaar, Silvio Danese. Management of gastrointestinal and liver diseases during pregnancy. Gut 2014; 63(6): 1014 doi: 10.1136/gutjnl-2013-305418
|
| 83 |
Monica Kumar, Laura Ray, Sudha Vemuri, Teresa A. Simon. Pregnancy outcomes following exposure to abatacept during pregnancy. Seminars in Arthritis and Rheumatism 2015; 45(3): 351 doi: 10.1016/j.semarthrit.2015.06.016
|
| 84 |
I. Belinchón, M. Velasco, M. Ara-Martín, S. Armesto Alonso, O. Baniandrés Rodríguez, L. Ferrándiz Pulido, M. García-Bustinduy, J.A. Martínez-López, N. Martínez Sánchez, A. Pérez Ferriols, E. Pérez Pascual, R. Rivera Díaz, R. Ruiz-Villaverde, R. Taberner Ferrer, A. Vicente Villa, J.M. Carrascosa. Consenso sobre las actuaciones a seguir durante la edad fértil, el embarazo, el posparto y la lactancia en pacientes con psoriasis. Actas Dermo-Sifiliográficas 2021; 112(3): 225 doi: 10.1016/j.ad.2020.10.002
|
| 85 |
Thomas Billiet, Paul Rutgeerts, Marc Ferrante, Gert Van Assche, Séverine Vermeire. Targeting TNF-α for the treatment of inflammatory bowel disease. Expert Opinion on Biological Therapy 2014; 14(1): 75 doi: 10.1517/14712598.2014.858695
|
| 86 |
N. Ghalandari, R. J. E. M. Dolhain, J. M. W. Hazes, E. P. van Puijenbroek, M. Kapur, H. J. M. J. Crijns. Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review. Drugs 2020; 80(16): 1699 doi: 10.1007/s40265-020-01376-y
|